SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026298
Filing Date
2021-11-12
Accepted
2021-11-12 08:02:29
Documents
51
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20210930_10q.htm   iXBRL 10-Q 722521
2 EXHIBIT 10.3 ex_303773.htm EX-10.3 166878
3 EXHIBIT 31.1 ex_303774.htm EX-31.1 14316
4 EXHIBIT 31.2 ex_303775.htm EX-31.2 14373
5 EXHIBIT 32.1 ex_303776.htm EX-32.1 6291
6 EXHIBIT 32.2 ex_303777.htm EX-32.2 6199
  Complete submission text file 0001437749-21-026298.txt   3304795

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA govx-20210930.xsd EX-101.SCH 32997
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20210930_cal.xml EX-101.CAL 27063
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20210930_def.xml EX-101.DEF 234478
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20210930_lab.xml EX-101.LAB 203267
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20210930_pre.xml EX-101.PRE 248459
12 EXTRACTED XBRL INSTANCE DOCUMENT govx20210930_10q_htm.xml XML 267459
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 211399721
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences